Corbus Pharmaceuticals (CRBP), incorporated in Delaware, announced a material underwritten public offering on October 30, 2025, utilizing a Form S-3 shelf registration. The offering, led by Jefferies LLC and including Piper Sandler as a joint book-running manager, is expected to close around November 3, 2025.
The transaction involves the sale of approximately 4.74 million Common Shares and 1.03 million Pre-funded Warrants, targeting gross proceeds around \(70.5 million to \)75 million based on unit pricing near $13.00. The underwriters have an option to purchase up to 865,384 additional shares.
...